Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Post by ninjadearon Sep 01, 2015 2:38pm

130 Views

Post# 24069196

Hi guys I was lucky to buy .72

dont care about stock price.
Can we talk about this upcomming date and perhapse, the price of..er wait.. the importance of stock success, I mean not stock I'm asking what could possibly be wrong with the .72 price, They arent taking much debt, they have a good working method of cure, What on earth would make this share faultier?

Bullboard Posts

Paramount Resources signs $3.32 billion asset sale